Somatic Dysfunction in Patients With Acute Cerebrovascular Disease

Part of paid clinical trials in Sacramento, California.

Sponsor
University of California, Davis
Study ID
NCT06605014
Status
Recruiting
Apply to this trial

Conditions

  • Health-Related Quality-of-Life
  • Osteopathic Manipulation
  • Reproducibility of Results
  • Stroke, Acute
  • TIA

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The goals of this observational study are to test the reliability of a new, standardized physical examination method to identify motion problems within joints or groups of joints among adult asymptomatic volunteers and in patients hospitalized with stroke or stroke-like episodes (e.g., transient ischemic attack, TIA). The main questions this investigation aims to answer are: * Can different, independent providers reliability quantify motion pattern problems using a systematic approach called, The Functional Pathology of the Musculoskeletal System (FPMSS) model? * Are there differences in joint(s) motion patterns among asymptomatic volunteers, patients with TIA (people with brain disease without new neurologic disability), and recent ischemic stroke (patients with new stroke-related-disability, e.g., paralysis)? * Is there an association between joint(s) motion impairment severity and stroke survivor outcomes? Participants (asymptomatic and those with stroke) will undergo a set of repeated paired, musculoskeletal physical exams by independent providers blinded to each other's assessments and patient information. Researchers will compare the severity, location, and quantity of joint(s) motion impairment between these three groups with the physical examination methodology (FPMSS). Clinical information (e.g., test results, diagnoses, brain imaging, medical history) will be collected from patients admitted for TIA and stroke. Enrolled participants with recent stroke will complete a survey three months after hospitalization to determine their self-perceived quality-of-life.

Key Dates

Start date
Sep 1, 2023
Status verified
Sep 2025
Primary completion
Jun 30, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
120 participants (estimated)

Arms

  • Arm: SOMADC-AC Cohort
    1. Asymptomatic adult volunteers 2. Patients admitted with TIA 3. Patients admitted with acute ischemic stroke

Primary Outcome Measure

Examiner Rater-Reliability [ Time Frame: 3 to 14 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California Davis Medical CenterSacramentoCalifornia95817
Alan Yee, D.O.
Alan Yee, D.O. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Sacramento, CA

By research site
University of California Davis Medical Center· Sacramento, CA

Related Studies